British American Tobacco — Moving to a smokeless world

British American Tobacco (LSE: BATS)

Last close As at 20/02/2025

GBP30.35

5.00 (0.17%)

Market capitalisation

GBP66,821m

More on this equity

Research: Consumer

British American Tobacco — Moving to a smokeless world

British American Tobacco’s (BAT’s) strategy is to become a predominantly smokeless business, generating more than 50% of revenue (FY24: 17.5%) from smokeless products by FY35. The industry backdrop is favourable, with higher revenue growth expected as consumers move to new reduced-risk products. Having transformed its capabilities through scientific research, customer engagement and product innovation, management believes focused investment should enable BAT to continue capturing the enhanced growth opportunity with better returns. BAT is confident of higher profit growth in FY25 before hitting its full stride of 4–6% pa sustainable growth from FY26, comparable to BAT’s growth rates before FY22.

Russell Pointon

Written by

Russell Pointon

Director of Content, Consumer and Media

Consumer

QuickView

18 February 2025

Price 3,095.00p
Market cap £68,273m
Price Performance
Share details
Code BATS
Listing LSE

Shares in issue

2,205.9m

Net cash/(debt) at 31 December 2024

£31,253.0m

Business description

British American Tobacco manufactures and sells nicotine globally. These include cigarettes and reduced-risk products such as vapes, heated products and oral products.

Bull points

  • BAT estimates the global nicotine market will grow at a CAGR of 4.6% from 2024–35 versus 3.8% from 2017–23, including double-digit growth from new categories in addition to 0-2% growth from combustibles (volume declines, pricing positive).
  • Only 10% of the world’s one billion smokers currently use new smokeless products.
  • High cash conversion enables progressive dividend (FY24 was 26th consecutive year of dividend growth in sterling), further share buybacks, debt reduction and potential bolt-on M&A.

Bear points

  • Potential financial losses from product liability and regulatory changes.
  • Considerable divergence between countries on how to regulate new categories, including the banning of products despite reduced health risks.
  • Competition from illegal products and illicit trade as external parties seek to avoid excise duty or take advantage of lack of regulation.

Analysts

Russell Pointon
+44 (0)20 3077 5700
Nick Hawkins
+44 (0)20 3077 5700

British American Tobacco is a research client of Edison Investment Research Limited

Towards higher growth and strong cash generation

BAT’s financial performance was below historical norms in FY23 and FY24, mainly due to weakness in the US. FY24 is seen as a transition year, following the implementation of commercial changes in the US and enhanced innovation in new categories, which drove a relative improvement in growth in H224. Management guides to gradual improvement in organic constant currency growth for profit from operations from 1.4% in FY24 to 1.5–2.5% (ex Canada) in FY25 before delivering 4–6% pa from FY26, above revenue growth of 3–5%. Medium-term positive drivers for BAT’s revenue are: (1) improving US financial performance; (2) momentum/innovation in new categories; and (3) continued strong performance in the Americas and Europe. Over the medium term, revenue growth should be complemented by further cost efficiencies (c £2bn in FY26–30 vs £1.2bn in FY23–25) and greater profit contribution from new categories as they scale, driving greater profit growth. Key headwinds are from the US: macroeconomic pressures on consumers and limited enforcement actions to tackle the large illicit vapour market. Changes in regulations and duties in Australia and Bangladesh will dampen profit growth by 2pp in FY25. BAT expects operating cash conversion will remain at 90%+, a target it has regularly exceeded at 100% in the last five years, generating over £50bn free cash flow through 2030. This will fund a growing dividend (in sterling), debt reduction, further share buybacks (FY24: £700m, FY25: £900m) and potential bolt-on M&A.

Attractive dividend yield versus global peers

BAT offers an attractive prospective dividend yield versus the average for its global peers of 5.4%. The prospective FY25e P/E multiple of 8.4x compares favourably to the average for its global peers of 13.0x, but reflects lower projected growth in EPS for BAT of c 2% and 6% in FY24 and FY25 versus c 9% and c 8% for the peers. An improvement in BAT’s growth would be helpful for its valuation on a relative basis.

Source: BAT, LSEG Data & Analytics. Note: Consensus unlikely to reflect estimate changes following FY24 results. EBIT adjusted profit from operations.

Consensus estimates

Year end Revenue (£m) EBIT (£m) EPS (p) DPS (p) P/E (x) Yield (%)
12/23 27,283.0 12,465.0 375.60 235.52 8.2 7.6
12/24 25,867.0 11,890.0 362.52 240.24 8.5 7.8
12/25e 26,477.0 11,925.8 369.49 246.08 8.4 8.0
12/26e 27,134.0 12,288.7 391.51 254.75 7.9 8.2
The author of this report holds shares in British American Tobacco and, as such, has a financial interest in the subject of this analysis.

General disclaimer and copyright

This report has been commissioned by British American Tobacco and prepared and issued by Edison, in consideration of a fee payable by British American Tobacco. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2025 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on British American Tobacco

View All

Latest from the Consumer sector

View All Consumer content

Research: TMT

Wilmington — Supporting clients in regulated markets

Wilmington’s H125 results show its strong positioning in growing governance, risk and compliance (GRC) regulated markets. Revenues from ongoing business were 16% ahead (+3% organic), with a step up in adjusted PBT margin from 21% to 25%. The level of repeat revenues in the continuing business (including recurring revenues), edged up 1% to 72%. The October 2024 acquisition of Phoenix Health & Safety expanded the training and education offering in the substantial health, safety and environmental (HSE) regulated area. Net cash was £31.3m at 31 December, post the £29.2m spend on Phoenix, giving plenty of firepower for further M&A. Current trading is in line with full-year market expectations.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free